Literature DB >> 20101529

Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?

Bo Su1, Xinglong Wang, David Bonda, Gorge Perry, Mark Smith, Xiongwei Zhu.   

Abstract

Mitochondria are dynamic organelles that undergo continuous fission and fusion, which could affect all aspects of mitochondrial function. Mitochondrial dysfunction has been well documented in Alzheimer's disease (AD). In the past few years, emerging evidence indicates that an imbalance of mitochondrial dynamics is involved in the pathogenesis of AD. In this review, we discuss in detail the abnormal mitochondrial dynamics in AD and how such abnormal dynamics may impact mitochondrial and neuronal function and contribute to the course of disease. Based on this discussion, we propose that mitochondrial dynamics could be a potential therapeutic target for AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101529      PMCID: PMC3129743          DOI: 10.1007/s12035-009-8095-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  148 in total

1.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

2.  MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology.

Authors:  Nobuhiro Nakamura; Yasuo Kimura; Masaki Tokuda; Shinji Honda; Shigehisa Hirose
Journal:  EMBO Rep       Date:  2006-08-25       Impact factor: 8.807

3.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

4.  Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

Authors:  Karina Acevedo-Torres; Lexsy Berríos; Nydia Rosario; Vanessa Dufault; Serguei Skatchkov; Misty J Eaton; Carlos A Torres-Ramos; Sylvette Ayala-Torres
Journal:  DNA Repair (Amst)       Date:  2008-11-20

5.  Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence.

Authors:  Seungmin Lee; Seon-Yong Jeong; Won-Chung Lim; Sujeong Kim; Yong-Yea Park; Xuejun Sun; Richard J Youle; Hyeseong Cho
Journal:  J Biol Chem       Date:  2007-06-01       Impact factor: 5.157

6.  Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles.

Authors:  B Trinczek; A Ebneth; E M Mandelkow; E Mandelkow
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

7.  Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons.

Authors:  W G Annaert; L Levesque; K Craessaerts; I Dierinck; G Snellings; D Westaway; P S George-Hyslop; B Cordell; P Fraser; B De Strooper
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

8.  Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats.

Authors:  Gjumrakch Aliev; Jiankang Liu; Justin C Shenk; Kathryn Fischbach; Gerardo J Pacheco; Shu G Chen; Mark E Obrenovich; Walter F Ward; Arlan G Richardson; Mark A Smith; Eldar Gasimov; George Perry; Bruce N Ames
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

9.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

10.  Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.

Authors:  Matthias L Jauslin; Thomas Meier; Robin A J Smith; Michael P Murphy
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  33 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

Review 2.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

3.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

4.  Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Authors:  Vladimir Volloch; Bjorn Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2020

5.  Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.

Authors:  Vladimir Volloch; Bjorn R Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2019-11-20

Review 6.  Drug development for rare mitochondrial disorders.

Authors:  Orest Hurko
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Characterization and Discovery of a Selective Small-Molecule Modulator of Mitochondrial Complex I Targeting a Unique Binding Site.

Authors:  Jakob C Green; Yuqi Jiang; Liu He; Yiming Xu; Dong Sun; Timothy Keoprasert; Christopher Nelson; Unsong Oh; Edward J Lesnefsky; Glen E Kellogg; Qun Chen; Shijun Zhang
Journal:  J Med Chem       Date:  2020-10-02       Impact factor: 7.446

Review 8.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 9.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

10.  Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation.

Authors:  Milena Pinto; Alicia M Pickrell; Hirokazu Fukui; Carlos T Moraes
Journal:  Neurobiol Aging       Date:  2013-05-21       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.